Skip to main content
SpringerLink
Log in

Initiale Therapie des Status epilepticus

Welche Therapie erfolgt zu Hause und im Rettungswagen?

Initial treatment of status epilepticus

Which treatment is carried out at home and in the ambulance?

  • Leitthema
  • Published:
Zeitschrift für Epileptologie Aims and scope Submit manuscript

Zusammenfassung

Der Status epilepticus gehört zu den wichtigsten neurologischen Notfallsituationen, die eine sofortige medizinische Behandlung erfordern. Eine schnelle und ausreichend dosierte Behandlung ist wichtig, um das Therapieoutcome zu optimieren und die Mortalität zu reduzieren. Hier geben wir einen Überblick über mögliche Behandlungsstrategien des Status epilepticus im häuslichen Umfeld und im Rettungswagen.

Abstract

Status epilepticus is one of the major neurological emergency situations requiring immediate medical treatment. Rapid and sufficiently dosed treatment is essential to optimize outcome and to reduce mortality. This article gives an overview about the possible treatment options of status epilepticus in the domestic environment and by paramedics in the ambulance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Abou-Khalil B, Wheless J, Rogin J, Wolter KD, Pixton GC, Shukla RB, Sherman NA, Sommerville K, Goli V, Roland CL (2013) A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures. Epilepsia 54:1968–1976

    Article  CAS  Google Scholar 

  2. Agarwal SK, Kriel RL, Brundage RC, Ivaturi VD, Cloyd JC (2013) A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers. Epilepsy Res 105:362–367

    Article  CAS  Google Scholar 

  3. Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O’Neil N, Neuhaus JM, Segal MR, Lowenstein DH (2001) A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 345:631–637

    Article  CAS  Google Scholar 

  4. Alvarez V, Lee JW, Drislane FW, Westover MB, Novy J, Dworetzky BA, Rossetti AO (2015) Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison. Epilepsia 56(8):1275–1285. https://doi.org/10.1111/epi.13056

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Arya R, Gulati S, Kabra M, Sahu JK, Kalra V (2011) Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study. Epilepsia 52:788–793

    Article  CAS  Google Scholar 

  6. Ashrafi MR, Khosroshahi N, Karimi P, Malamiri RA, Bavarian B, Zarch AV, Mirzaei M, Kompani F (2010) Efficacy and usability of buccal midazolam in controlling acute prolonged convulsive seizures in children. Eur J Paediatr Neurol 14:434–438

    Article  Google Scholar 

  7. Betjemann JP, Lowenstein DH (2015) Status epilepticus in adults. Lancet Neurol 14:615–624

    Article  Google Scholar 

  8. Brigo F, Bragazzi NL, Bacigaluppi S, Nardone R, Trinka E (2016) Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials. Epilepsy Behav 64:29–36. https://doi.org/10.1016/j.yebeh.2016.09.020

    Article  PubMed  Google Scholar 

  9. Castle JR, Youssef JE, Branigan D, Newswanger B, Strange P, Cummins M, Shi L, Prestrelski S (2016) Comparative Pharmacokinetic/Pharmacodynamic study of liquid stable Glucagon versus Lyophilized Glucagon in type 1 diabetes subjects. J Diabetes Sci Technol 10(5):1101–1107. https://doi.org/10.1177/1932296816653141

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Crawford TO, Mitchell WG, Snodgrass SR (1987) Lorazepam in childhood status epilepticus and serial seizures: effectiveness and tachyphylaxis. Neurology 37:190–195

    Article  CAS  Google Scholar 

  11. Crevoisier C, Delisle MC; Joseph I, Foletti G (2003) Comparative Single-Dose Pharmacokinetics of Clonazepam following Intravenous, Intramuscular and Oral Administration to Healthy Volunteers. Eur Neurology 49:173–177

    CAS  Google Scholar 

  12. Delorenzo RJ, Garnett LK, Towne AR, Waterhouse EJ, Boggs JG, Morton L, Choudhry MA, Barnes T, Ko D (1999) Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia 40(2):164–169. https://doi.org/10.1111/j.1528-1157.1999.tb02070.x

    Article  CAS  PubMed  Google Scholar 

  13. Dreifuss FE, Rosman NP, Cloyd JC, Pellock JM, Kuzniecky RI, Lo WD, Matsuo F, Sharp GB, Conry JA, Bergen DC, Bell WE (1998) A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med 338(26):1869–1875. https://doi.org/10.1056/nejm199806253382602

    Article  CAS  PubMed  Google Scholar 

  14. Fisgin T, Gurer Y, Tezic T, Senbil N, Zorlu P, Okuyaz C, Akgun D (2002) Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study. J Child Neurol 17:123–126

    Article  Google Scholar 

  15. Goodkin HP, Yeh JL, Kapur J (2005) Status epilepticus increases the intracellular accumulation of GABAA receptors. J Neurosci 25(23):5511–5520. https://doi.org/10.1523/jneurosci.0900-05.2005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Goodkin HP, Sun C, Yeh JL, Mangan PS, Kapur J (2007) GABAA receptor internalization during seizures. Epilepsia 48(Suppl 5):109–113. https://doi.org/10.1111/j.1528-1167.2007.01297.x

    Article  CAS  PubMed  Google Scholar 

  17. De Haan GJ, Van Der Geest P, Doelman G, Bertram E, Edelbroek P (2010) A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia 51:478–482

    Article  Google Scholar 

  18. Holsti M, Dudley N, Schunk J, Adelgais K, Greenberg R, Olsen C, Healy A, Firth S, Filloux F (2010) Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med 164:747–753

    Article  Google Scholar 

  19. Kapur J, MacDonald RL (1997) Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci 17:7532–7540

    Article  CAS  Google Scholar 

  20. Kay L, Reif PS, Belke M, Bauer S, Frund D, Knake S, Rosenow F, Strzelczyk A (2015) Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures. Epilepsia 56:1408–1414

    Article  CAS  Google Scholar 

  21. Kortland LM, Alfter A, Bahr O, Carl B, Dodel R, Freiman TM, Hubert K, Jahnke K, Knake S, von Podewils F, Reese JP, Runge U, Senft C, Steinmetz H, Rosenow F, Strzelczyk A (2016) Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany. Epilepsia 57:2056–2066

    Article  Google Scholar 

  22. Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch M (2000) Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ 321:83–86

    Article  CAS  Google Scholar 

  23. Lowenstein DH, Alldredge BK (1993) Status epilepticus at an urban public hospital in the 1980s. Neurology 43:483–488

    Article  CAS  Google Scholar 

  24. Lowenstein DH, Bleck T, MacDonald RL (1999) It’s time to revise the definition of status epilepticus. Epilepsia 40:120–122

    Article  CAS  Google Scholar 

  25. Mahmoudian T, Zadeh MM (2004) Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy Behav 5:253–255

    Article  CAS  Google Scholar 

  26. Mccormick EM, Lieh-LAI M, Knazik S, Nigro M (1999) A prospective comparison of midazolam and lorazepam in the initial treatment of status epilepticus in the pediatric patient. Epilepsia 40(Suppl 7):160

    Google Scholar 

  27. Mcintyre J, Robertson S, Norris E, Appleton R, Whitehouse WP, Phillips B, Martland T, Berry K, Collier J, Smith S, Choonara I (2005) Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 366:205–210

    Article  CAS  Google Scholar 

  28. Mcmullan J, Sasson C, Pancioli A, Silbergleit R (2010) Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med 17:575–582

    Article  Google Scholar 

  29. Meldrum BS, Brierley JB (1973) Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol 28:10–17

    Article  CAS  Google Scholar 

  30. Meldrum BS, Horton RW (1973) Physiology of status epilepticus in primates. Arch Neurol 28:1–9

    Article  CAS  Google Scholar 

  31. Chamberlain JM, Okada P, Holsti M, Mahajan P, Brown KM, Vance C, Gonzalez V, Lichenstein R, Stanley R, Brousseau DC, Grubenhoff J, Zemek R, Johnson DW, Clemons TE, Baren J, Pediatric Emergency Care Applied Research Network (PECARN) (2014) Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA 311:1652–1660

    Article  Google Scholar 

  32. Prasad M, Krishnan PR, Sequeira R, Al-Roomi K (2014) Anticonvulsant therapy for status epilepticus. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD003723.pub3

    Article  PubMed  Google Scholar 

  33. Rice AC, Delorenzo RJ (1999) N‑methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam. Neuroscience 93:117–123

    Article  CAS  Google Scholar 

  34. Rosenow F (2012) Status epilepticus im Erwachsenenalter. In: Diener HC, Weimar C (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart

    Google Scholar 

  35. Sanchez Fernandez I, Gainza-Lein M, Loddenkemper T (2017) Nonintravenous rescue medications for pediatric status epilepticus: A cost-effectiveness analysis. Epilepsia 58:1349–1359

    Article  CAS  Google Scholar 

  36. Scott RC, Besag FM, Neville BG (1999) Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 353:623–626

    Article  CAS  Google Scholar 

  37. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W, for the NETT investigators (2012) Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus. N Engl J Med 366:591–600

    Article  CAS  Google Scholar 

  38. Singhi S, Murthy A, Singhi P, Jayashree M (2002) Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol 17:106–110

    Article  Google Scholar 

  39. Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, Katsarou N, Hamer HM, Status Epilepticus Study Group (2001) Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 42:714–718

    Article  CAS  Google Scholar 

  40. Strzelczyk A, Knake S, Oertel WH, Rosenow F, Hamer HM (2013) Inpatient treatment costs of status epilepticus in adults in Germany. Seizure 22:882–885

    Article  Google Scholar 

  41. Strzelczyk A, Kay L, Kellinghaus C, Knake S, von Blomberg A, Willems LM, Rosenow F (2017) Concepts for Prehospital and initial in-hospital therapy of status Epilepticus. Neurol Int Open 01(03):E217–E223. https://doi.org/10.1055/s-0043-110486

    Article  Google Scholar 

  42. Thakker A, Shanbag P (2013) A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures. J Neurol 260:470–474

    Article  CAS  Google Scholar 

  43. Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH (2015) A definition and classification of status epilepticus – report of the Ilae task force on classification of status epilepticus. Epilepsia 56:1515–1523

    Article  Google Scholar 

  44. Welch RD, Nicholas K, Durkalski-Mauldin VL, Lowenstein DH, Conwit R, Mahajan PV, Lewandowski C, Silbergleit R (2015) Neurological Emergencies Treatment Trials (Nett) Network Investigators. Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population. Epilepsia 56:254–262

    Article  CAS  Google Scholar 

  45. Wu W, Zhang L, Xue R (2016) Lorazepam or diazepam for convulsive status epilepticus: A meta-analysis. J Clin Neurosci 29:133–138

    Article  Google Scholar 

  46. Zhao ZY, Wang HY, Wen B, Yang ZB, Feng K, Fan JC (2016) A comparison of Midazolam, Lorazepam, and diazepam for the treatment of status Epilepticus in children: a network Meta-analysis. J Child Neurol 31:1093–1107

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Epilepsiezentrum Münster-Osnabrück, Klinik für Neurologie mit Institut für Translationale Neurologie – Epileptologie, Universitätsklinikum Münster, Münster, Deutschland

    Gabriel Möddel

  2. Epilepsiezentrum Münster-Osnabrück, Klinik für Neurologie, Klinikum Osnabrück GmbH, Am Finkenhügel 1, 49076, Osnabrück, Deutschland

    Christoph Kellinghaus

  3. Epilepsiezentrum Frankfurt Rhein-Main, Zentrum der Neurologie und Neurochirurgie, Goethe-Universität, Frankfurt am Main, Deutschland

    Adam Strzelczyk

  4. Epilepsiezentrum Hessen, Klinik für Neurologie, Philipps-Universität, Marburg (Lahn), Deutschland

    Adam Strzelczyk

Authors
  1. Gabriel Möddel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christoph Kellinghaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adam Strzelczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Kellinghaus.

Ethics declarations

Interessenkonflikt

G. Möddel erhielt Beratungs- und Referentenhonorare von Desitin, Eisai und UCB Pharma und Electrical Geodesics. C. Kellinghaus erhielt Beratungs- und Referentenhonorare von Cerbomed, Desitin, Eisai und UCB Pharma. A. Strzelczyk erhielt Beratungs‑, Referentenhonorare und/oder Unterstützung für Forschungsvorhaben von Desitin Arzneimittel, Eisai, LivaNova, Sage Therapeutics, UCB Pharma und Zogenix.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Möddel, G., Kellinghaus, C. & Strzelczyk, A. Initiale Therapie des Status epilepticus. Z. Epileptol. 31, 245–249 (2018). https://doi.org/10.1007/s10309-018-0204-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10309-018-0204-z

Schlüsselwörter

Keywords

Search

Navigation